JULIANN VISSER: Open Payments
NPI 1922309848 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 14 payments from 4 companies in 2025. Trend: 2023 $241 · 2024 $300 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $200 |
| ABBVIE INC. | 3 | $78 |
| UCB, Inc. | 3 | $61 |
| Galderma Laboratories, L.P. | 1 | $22 |
Products named: Rhapsido, Bimzelx, XOLAIR, NEMLUVIO, BOTOX.
Industry payments across ID — which companies pay providers there.
